Amil Družić and Emina Bičakčić: Meet the Experts of VIRO 2025

The Global Voices in Renal Oncology (VIRO) Virtual Congress, organized by OncoDaily, will be held on September 11–12, 2025. Chaired by Dr. Rana R. McKay with co-chair Dr. Yüksel Ürün, this year’s program will feature around 50 leading experts in renal oncology from across the globe, sharing cutting-edge updates and future perspectives.

• The congress is free to attend.
• Register via the link.

Co-Chair of VIRO

Images

Name

Rana McKay Professor of Medicine and Urology at UC San Diego Health Co-leader of the GU Oncology Program at Moores Cancer Center As Co-Chair of VIRO, Dr. Rana McKay (University of California, San Diego) opened the congress with her talk on  “Future Directions: Emerging Agents and Combinations.” She emphasized the momentum in renal cell carcinoma (RCC) research, highlighting how novel immunotherapies, targeted drugs, and rational combination strategies are reshaping patient care. Dr. McKay underscored the importance of personalized, biomarker-driven approaches and global collaboration, aiming to optimize survival and quality of life worldwide.

Spotlight on Amil Družić and Emina Bičakčić

Dr. Amil Družić is an Oncology and Radiotherapy Resident, and Dr. Emina Bičakčić is a Medical Doctor, both at the Clinical Center University of Sarajevo in Bosnia and Herzegovina. They are committed to advancing cancer diagnosis, treatment, and research within the Bosnian healthcare system.

At the Global Voices in Renal Oncology (VIRO) Virtual Congress 2025, Drs. Družić and Bičakčić will present on “The Current State of Renal Oncology in Bosnia and Herzegovina.” Their presentation will cover:

• The epidemiology and clinical management of renal cell carcinoma in Bosnia and Herzegovina.
• Local challenges including healthcare infrastructure, access to novel therapies, and multidisciplinary care integration.
• Recent advances and ongoing clinical research aimed at improving renal oncology outcomes in the region.
• Strategies for improving patient education, early diagnosis, and treatment adherence.

With their clinical insights and research focus, they aim to highlight opportunities and future directions for enhancing renal cancer care in Bosnia and Herzegovina.

Global Voices in Renal Oncology (VIRO) 2025